The LDN 2019 Conference
Watch and learn from LDN experts.
The 2019 LDN AIIC Conference had discussions on the following disorders: ALS, Alzheimer's, anxiety, arthritis, autism, autoimmune hepatitis, brain fog, cancer, CFS, complex regional pain syndrome (CPRS), Crohn's, depression, diabetes, dissociative disorder, Epstein Barr virus, fibromyalgia, glioma, Graves’ disease, Hashimoto's, infertility, irritable bowel, leaky brain, leukemia, Lupus, Lyme disease, lymphoma, mast cell activation syndrome (MCAS), melanoma, mental health, mesothelioma, migraines, monoclonal gammopathy of undetermined significance (MGUS), movement disorder, MS, multiple sclerosis, multisystem disorders, myelodysplastic syndromes, obesity, opioid withdrawal, pain, Parkinson's, pituitary dysfunction, premenstrual syndrome (pms), psoriasis, PTSD, recurrent vaginitis, restless leg syndrome (rls), rheumatoid, SMALL intestinal bacterial overgrowth (SIBO), Sjogren's, stress, thyroid, tired brain syndrome, trauma, traumatic brain injury, ulcerative colitis, vulvodynia.
Speakers
Akbar Khan, MD - LDN vs. Chemotherapy: One “Unproven” Therapy Against Another?
Armin Schwarzbach PhD, MD - Infections in Cancer and Autoimmune Disorders presented by Markus Berger
Elizabetheth Livengood NMD - LDN and MDD: A Case Study - Treating Depression in Patients with Autoimmune Conditions
Brian Udell MD - Low Dose Naltrexone - Key Ingredient in the biomedical Treatment of Autism Spectrum Disorder
Carrie Jones, ND, MPH - LDN and Cellular Hypothyroidism: When TSH is Normal but Reverse T3 is Elevated
Carrie Jones, ND, MPH - LDN and Cellular Hypothyroidism: Why you can't convert T4 into T3
Cory Tichauer ND - Immune Dysfunction in Post-Treatment Lyme Disease: Using Naltrexone to Balance Chronic Inflammation
Dana Keaton ND - Patient selection and inflammation
Dana Keaton ND - The scope of patient selection for LDN
Dr Harpal Bains MBBS - The role LDN plays in the body's hormonal symphony: how a well-conducted orchestra enhances the efficacy of LDN.
Dr Harpal Bains MBBS - Bioidentical hormones+asthetic+lifestyle
Elissa Mullen ND - Sleep - PTSD HPA Axis Dysregulation - LDN & The Gut Brain Barrier
Galyn Forster, MS, LPC - Treating Psychiatric Disorders with LDN Case Studies:Trauma-stress disorder, dissociative disorder, anxiety, phobia, pain and hypervigilance
Ginevra Liptan MD - Turning down the volume on fibromyalgia pain
Kent Holtorf, M.D - Causes of Hashimoto's
Kent Holtorf, M.D - LDN should be considered a first-line therapy for CFS/FM
Linda Elsegood - LDN, MS, The LDN Research Trust and Me
Mark Cooper, PhD - LDN, Endosomes and the Nanophysilogy of Autoimmune Movement Disorders
Michael Ruscio, DC - The Gut-Thyroid Connection, Profound but Under Appreciated
Nasha Winters, ND - Using LDN to Quell the Over-Reactive Autoimmune Conditions Triggered by Many of Today's Cancer Drugs
Nasha Winters, ND - Quelling the side effects of immune therapies with LDN
Olga Cortez, MD - LDN Use in Women's Health
Pamela Smith, MD - LDN and Multiple Sclerosis
Pamela Smith, MD - LDN Use in Cognitive Decline, Lyme Disease, and Hashimoto’s Thyroiditis
Paul Battle, PA-C - Autoimmune Hepatitis
Prof Angus Dalgleish, MD - The role of LDN in cancer managemen
Sarah Zielsdorf, MD, MS - Graves' Disease
Sarah Zielsdorf, MD, MS - Traumatic Brain Injury: Low Dose Naltrexone and Microglial Modification
Sarah Zielsdorf, MD, MS - “Just Try LDN”: 3 years of insight from over 1,000 patients use of Low Dose Naltrexone
Stephen Dickson BSC (hons) MRPharmS - Mechanism of Action of Low Dose Naltrexone (LDN)
Steve Ottersberg MS - LDN, pain and immunity
Ted Cole, DO - The Use of LDN and Amino Acids in Parkinson's Disease
Ted Cole, DO - The Use of LDN in Parkinson's Disease
Ulrich Lanius, PhD - Naltrexone Dosing in Traumatic Stress and Dissociative Symptoms
Yoon Hang "John" Kim, MD - Treating chronic pain with low dose naltrexone and ultralow dose naltrexone
Yoon Hang "John" Kim, MD - Getting the most of LDN treatment and Beyond LDN
Mona Morstein ND - Using Low Dose Naltrexone To Help SIBO Patients
Andrew David Shiller MD - Is LDN a magic bullet for Fibromyalgia and Chronic Illness?
Sajad Zalzala, MD - What Patients Need to Know About Telemedicine
Amy Lamb Pharm - A Pharmacist's Perspective on Comprehensive Immune Health Consultations and Applications of LDN
Jill Cottel, MD - Treatment of Chronic Pain in a Free Clinic Setting
Leonard Weinstock, MD - Mast cell activation syndrome and potential role for LDN
Debbie Rice ND - LDN and vulvodynia
Scott Zashin MD - Treatment of Sjogren's Syndrome with LDN
Igor Schwartzman ND - The Art of LDN Prescribing In Hashimoto’s thyroiditis
Tara Thompson, PharmD - Compounding 101: The Basics of Compounding with Naltrexone
Jill Brook MA - Intermittent Fasting
Lesli Bitel, MBA, RDN, LDN - Client Attraction Secrets: Become a Sought After Expert With a Full Practice of Ideal, Committed Clients (Regardless of Insurance)
Andy Stein, PharmD - LDN for Opthalmic use
Samyadev Datta, MD - Pharmacology of Naltrexone Low dose Naltrexone in Chronic Pain Management
Michelle Moser, Pharm - Making a difference
Phil Boyle MD - Low Dose Naltrexone treatment for Premenstrual Syndrome - PMS
James Iversen - Safety and Quality in Low-Dose Naltrexone Compounding
Debbie Hamilton, MD - Latest Th17 Research
Amber Myers, PharmD - Ocular for Naltrexone>
Question and Answer Sessions
Friday Morning
Friday Afternoon
Saturday Morning
Saturday Afternoon
Sunday
Intellectual Property Rights
The intellectual property rights (including without limitation copyright and database rights) to the content in this website are owned by or licensed to the LDN Research Trust unless otherwise indicated.
Website content may be downloaded for personal, non-commercial use only. In all other cases, content originally published on the website may only be reproduced, stored, published or otherwise distributed in any form, with the written prior permission of the LDN Research Trust.